Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 8/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.70 |
| ▸ | MAPT | P10636 | 6/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | HPGD | P15428 | 3/20 | 0.70 |
| ▸ | GLA | P06280 | 2/20 | 0.70 |
| ▸ | CASP1 | P29466 | 1/20 | 0.70 |
| ▸ | CASP7 | P55210 | 1/20 | 0.70 |
| ▸ | ATM | Q13315 | 1/20 | 0.70 |
| ▸ | ABL1 | P00519 | 1/20 | 0.68 |
| ▸ | CFTR | P13569 | 3/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29400478 | 1.00 | GAA (0.70) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL8717841 | 0.88 | GAA (0.57) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL1403643 | 0.86 | GAA (0.72) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL7623605 | 0.84 | GAA (0.70) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL6168887 | 0.84 | GAA (0.66) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL30660134 | 0.83 | MAPT (0.48) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL29358 | 0.82 | KDM4E (1.00) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL616715 | 0.82 | GAA (1.00) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL4826905 | 0.82 | ALDH1A1 (0.68) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL1129582 | 0.82 | ALDH1A1 (0.68) | GAAALDH1A1KDM4EMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108033891-A | The synthetic method of 3- amino-4-methoxyl carbonyl aniline | 武汉理工大学 | 2018-05-15 | — | — | CN | claimed |
| US-6805718-B2 | USING AROMATIC AMINE, NAPHTHOL OR AMINONAPHTHALENE AND ENZYME | NOVOZYMES A/S (DK) | 2004-10-19 | — | — | US | claimed |
| US-20030226215-A1 | Enzymatic method for textile dying | NOVOZYMES NORTH AMERICA, INC. (US) | 2003-12-11 | — | — | US | claimed |
| WO-2003016615-A1 | SINGLE BATH PROCESS FOR BLEACHING AND DYEING TEXTILES | NOVOZYMES NORTH AMERICA, INC. (US) | 2003-02-27 | — | — | WO | claimed |
| EP-1266068-A1 | ENZYMATIC METHOD FOR TEXTILE DYEING | Novozymes North America, Inc. (US) | 2002-12-18 | — | — | EP | claimed |
| US-20010037532-A1 | Enzymatic method for textile dyeing | NOVOZYMES A/S (DK) | 2001-11-08 | — | — | US | claimed |
| US-6296672-B1 | PEROXIDASE, OXIDOREDUCTASE, LACCASE | NOVOZYMES A/S PATENTS (DK) | 2001-10-02 | — | — | US | claimed |
| WO-2001044563-A1 | ENZYMATIC METHOD FOR TEXTILE DYEING | NOVOZYMES NORTH AMERICA, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| US-4107151-A | FROM POLYISOCYANATE, CHAIN POLYOL, AROMATIC DIAMINE, POLYOL OR AMINO ALCOHOL WITH URETHANE BOND | IHARA CHEMICAL COMPANY CO., LTD. (JP) | 1978-08-15 | — | — | US | claimed |
| US-4054556-A | Polyurethanes cured with derivatives of 2,4-diamino-benzoic acid | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-10-18 | — | — | US | claimed |
| JP-63216820-A | — | — | None | — | — | JP | disclosed |
| CN-113544184-B | Composition for film formation, cured film, liquid crystal alignment film, and retardation film | JSR株式会社 | 2024-05-14 | — | — | CN | disclosed |
| US-20230357164-A1 | NOVEL QUINAZOLINE DERIVATIVE HAVING FLT3 INHIBITORY ACTIVITY, AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2023-11-09 | — | — | US | disclosed |
| US-20230359119-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| CN-109789378-B | Composite semipermeable membrane and spiral separation membrane element | 日东电工株式会社 | 2022-02-25 | — | — | CN | disclosed |
| EP-0109624-A2 | Process for producing shaped articles made from polyurethane-polyurea which may be cellular | BASF Aktiengesellschaft (DE) | 1984-05-30 | — | — | EP | disclosed |
| US-4107151-A | FROM POLYISOCYANATE, CHAIN POLYOL, AROMATIC DIAMINE, POLYOL OR AMINO ALCOHOL WITH URETHANE BOND | IHARA CHEMICAL COMPANY CO., LTD. (JP) | 1978-08-15 | — | — | US | disclosed |
| US-4054556-A | Polyurethanes cured with derivatives of 2,4-diamino-benzoic acid | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-10-18 | — | — | US | disclosed |
| US-4039514-A | SUBSTITUTED 2,4-DIAMINOBENZOIC ACID | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-08-02 | — | — | US | disclosed |
| US-3953496-A | ANTIPYRETICS, ANTI-ALLERGIC, ANTI-INFLAMMATORY AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357164-A1 | NOVEL QUINAZOLINE DERIVATIVE HAVING FLT3 INHIBITORY ACTIVITY, AND USE THEREOF | FLT3, ABL1, MCL1 | GAA 2989/4885ALDH1A1 3264/4885KDM4E 1481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.